NEW YORK (GenomeWeb News) – CombiMatrix today said that revenues in the fourth quarter jumped 18 percent year over year as revenues from core prenatal testing markets increased 57 percent.

For the three months ended Dec. 31, 2013, the Irvine, Calif.-based genetic testing laboratory saw revenues increase to $1.8 million from $1.5 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.